Relationship between the effect of interferon therapy and the change of hepatitis C virus non-structural 5B gene

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 4, 1999, Pages 345-351

  Horiike, Norio ^a   Michitaka, Kojiro ^a   Masumoto, Toshikazu ^a   Okura, Izumi ^a   Akbar, S M Fazle ^a   Onji, Morikazu ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatitis C virus; Interferon; Non structural 5B

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; AMINO ACID; NUCLEOTIDE; RECOMBINANT ALPHA2A INTERFERON; RNA DIRECTED RNA POLYMERASE; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENE;

EID: 0033379678     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01859.x     Document Type: Article

References (26)

1. 1 Kiyosawa K, SodeyamaT, Tanaka E et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
2. 2 Davis GL, Balart LA, Schiff ER et al. Treatment of chronic hepatitis C with recombinant interferon alpha. A multi-center randomized, controlled trial. N. Engl. J. Med. 1989; 321: 1501-6.
3. 3 Kanai K, Kako M and Okamoto H. HCV genotypes in chronic hepatitis C and the response to interferon. Lancet 1992; 339: 1543.
4. 4 Horiike N, Masumoto T, Michitaka K et al. The response to interferon in chronic hepatitis C due to mixed genotype infection. J. Gastroenterol. Hepatol. 1996; 11: 353-7.
5. 5 Nishiguchi S, Kuroki T, Nakatani S et al. Randomized trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis. Lancet 1995; 346: 1051-5.
6. 6 Enomoto N, Sakuma I, Asahina Y et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. J. Clin. Invest. 1995; 96: 224-30.
7. 7 Enomoto N, Sakuma I, Asahina Y et al. Mutations in the nonstructural protein 5A gene and the response to interferon in patients with chronic hepatitis C virus 1b infection. N. Engl. J. Med. 1996; 334: 77-81.
8. 8 Argos P. A sequence motif in many polymerases. Nucleic Acids Res. 1988; 16: 1021-5.
9. 9 Nelson DR, Gray AH, Kolberg JA et al. Variations of hepatitis C virus NS5B sequence (nucleotides 8261-8566) do not correlate with response to interferon-alpha therapy. J. Viral Hepatitis 1995; 2: 285-92.
10. 10 Desmet VJ, Gerber M, Hoofnagle JH et al. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
11. 11 Okamoto H, Sugiyama Y, Okada S et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: Application to clinical surveys and tracing infectious sources. J. Gen. Virol. 1992; 73: 673-9.
12. 12 Horiike N, Nonaka T, Kumamoto I et al. Hepatitis C virus plus-and minus-strand RNA in hepatocellular carcinoma and adjoining nontumorous liver. J. Med. Virol 1993; 41: 312-5.
13. 13 Michitaka K, Durazzo M, Tillmann HL et al. Analysis of hepatitis C virus genome in patients with autoimmune hepatitis type 2. Gastroenterology 1994; 106: 1603-10.
14. 14 Kato N, Hijitaka M, Ootsuyama Y et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl Acad. Sci. USA 1990; 87: 9524-8.
15. 15 Takamizawa A, Mori C, Fuke I et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 1991; 65: 1105-13.
16. 16 Okamoto H, Kojima M, Okada SI et al. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee. J. Virol. 1992; 190: 894-9.
17. 17 Tanaka T, Kato N, Nakagawa M et al. Molecular cloning of hepatitis C virus genome from a single Japanese carrier: Sequence variation within the same individual and among infected individuals. Virus Res. 1992; 23: 39-53.
18. 18 Hayashi N, Higashi H, Kaminaka K et al. Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome. J. Hepatol. 1993; 17: S94-107.
19. 19 Okamoto H, Okada S, Sugiyama Y et al. Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: Comparison with reported isolates for conserved and divergent regions. J. Gen. Virol. 1991; 72: 2697-704.
20. 20 Enomoto N, Takada A, Nakao T et al. There are two major types of hepatitis C virus in Japan. Biochem. Biophys. Res. Commun. 1990; 170: 1021-5.
21. 21 Behrens S-E, Tomei L and Francesco RD. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 1996; 15: 12-22.
22. 22 Lohmann V, Korner F, Herian U et al. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 1997; 71: 8416-28.
23. 23 Choo Q-L, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc. Natl Acad. Sci. USA 1991; 88: 2451-5.
24. 24 Sakugawa H, Nakasone H, Kinjo F et al. Clinical features of patients with chronic liver disease associated with hepatitis C virus genotype 1a/I in Okinawa, Japan. J. Gastroenterol. Hepatol. 1997; 12: 176-81.
25. 25 Nakazawa T, Kato N, Ohkoshi S et al. Characterization of the 5′ noncoding and structural region of the hepatitis responding differently to interferon treatment. J. Hepatol. 1994; 20: 623-9.
26. 26 Gale MJ, Korth MJ, Tang NM et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 1997; 230: 217-27.